Title : Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.

Pub. Date : 2015 Feb 28

PMID : 25444920






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma. vistusertib CREB regulated transcription coactivator 2 Mus musculus
2 Here we found that dual mTORC1/2 inhibitor AZD-2014 significantly inhibited RCC cell survival and growth, with higher efficiency than conventional mTORC1 inhibitors rapamycin and RAD001. vistusertib CREB regulated transcription coactivator 2 Mus musculus